Learn about the ISN’s work in advocacy below.
ISN contributes to WHO stakeholder consultation on tackling NCDs
In September 2016, ISN was invited to participate to a World Health Organisation (WHO) stakeholder consultation on the revision of Appendix 3 of the WHO NCD Global Action Plan 2013-2020. In the consultation response, ISN stressed the importance of kidney disease as a ’neglected’ disease, which raises important public health concerns worldwide and should be...
ISN participates in high-level WHO meeting in Copenhagen
Last week, ISN joined European health ministers and high-level representatives from 53 Member States at the 66th session of the World Health Organization (WHO) Regional Committee for Europe to discuss the challenges of tackling the burden of non-communicable diseases (NCDs) in Europe. At the meeting, ISN strongly supported the goals and implementation of the 2030...
ISN heads to Copenhagen for WHO Regional Committee
ISN will attend the 66th session of World Health Organization (WHO) Regional Committee for Europe, taking place in Copenhagen as of September 12, 2016. ISN Advocacy advisor Dr. Valerie Luyckx will contribute to the current discussions on health on behalf of the nephrology community in the context of the 2030 Agenda for Sustainable Development and...
The Global burden of CKD: a call for serious action
Chronic Kidney Disease (CKD) affects approximately 10% of the adult population, worldwide. While the distribution of those receiving and not getting renal replacement therapies(dialysis and transplantation), varies by country, the incidence and prevalence of CKD are remarkably consistent globally, though not always well documented. ISN’s latest endeavor, the ISN ‘Closing the Gaps’ initiative sets out to define...